Infections among pediatric transplant candidates: An approach to decision‐making

Abstract

Introduction The presence of infections in the immediate pretransplant period poses challenges in decision‐making. Delaying transplantation because of these infections may be required, but is associated with a risk to the potential recipient. The aim of this project was to develop a structured framework based on expert opinion to guide decision‐making regarding the safety of transplantation for candidates with infection immediately before transplant, and to show how this framework can be applied to clinical scenarios. Methods Categories were created as follows: Category A: no delay; Category B: brief delay (≤1 week); Category C: intermediate delay (>1 week); and Category D: more prolonged or indefinite delay. A survey containing 59 clinical scenarios was sent to members of the IPTA ID CARE committee. Answers were reviewed, and the level of agreement was characterized as follows: Level 1: ≥75% agreement; Level 2:51%‐74% agreement; and Level 3: ≤50% agreement. 95% CIs were calculated for the mean overall agreement across 59 scenarios. Results Among the panel, the agreement level ranged from 33% to 92% with the mean overall agreement across the 59 scenarios being 61%. For 7/59 scenarios, the lower bound of 95% CI was greater than 50%, indicating a difference at the 5% level of significance between the observed proportion and the chance level of 0.5. Summary The document provides expert opinion regarding the need to delay transplantation in the setting of different infections. The most important points in the decision to proceed to SOT included the urgency of transplantation and the severity of infection.

Community-Acquired Respiratory Viruses in Transplant Patients: Diversity, Impact, Unmet Clinical Needs

“…These considerations deserve explicit attention for pretransplant infections with IV-A/B, HRSV, HPIV, and HMPV in patients scheduled for allogeneic HCT. For SOT recipients, especially for lung transplant recipients, these issues are equally challenging and need to be balanced against the risk of transplant deferral, particularly in view of the organ donor shortage, the transplanted organ, and the availability of antiviral treatment (48,49).…”

Epidemiology and Risk Factors for Viral Infections in Pediatric Liver Transplant Recipients and Impact on Outcome

“…In our center, we wait approximately 2–3 weeks after the acute respiratory infection for transplant surgery in non-urgent LTR. However, consensus guidelines, based on multi-center surveys, recommended that the decision of transplant surgery should be tailored based on how urgent the transplant is and the type and severity of infecting pathogen [ 18 ].…”

Live vaccines after pediatric solid organ transplant: Proceedings of a consensus meeting, 2018

“…Strength of recommendations was ascertained by a previously used approach that reflected the degree of agreement among participants . The majority of recommendations achieved consensus with >90% of consortium participants “strongly agreeing” with each recommendation.…”

“…Strength of recommendations was ascertained by a previously used approach that reflected the degree of agreement among participants. 22 The majority of recommendations achieved consensus with >90% of consortium participants "strongly agreeing" with each recommendation. If the percentage of consortium participants that "strongly agree" with the recommendation was < 90%, the exact percentage of those that "strongly agree" with the recommendation is reported.…”